Summary & Overview
HCPCS J1812: Insulin (Fiasp), per 5 units
HCPCS Level II code J1812 denotes insulin (Fiasp), per 5 units, a HCPCS Level II drug billing code used nationally for fast-acting insulin dosing in ambulatory and pharmacy settings. This code matters because insulin remains a high-volume, high-cost therapeutic class with implications for outpatient diabetes care, medication management, and payer coverage policies.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact overview of the clinical context for Fiasp administration, typical sites where services are documented, and what to expect in billing practice. The publication outlines common modifiers and billing considerations, national benchmarks where available, and potential policy updates affecting HCPCS drug reporting and reimbursement.
The piece helps clinicians, billing staff, and policy analysts understand how J1812 maps to service lines (medication administration and pharmacy-dispensed drugs), where it is typically billed (outpatient clinics, physician offices, infusion centers, and pharmacies), and which major payers are relevant for coverage and claims processing. Data not provided in the input—such as specific associated taxonomies, ICD-10 pairings, and granular payer fee schedules—is noted as unavailable.
Billing Code Overview
HCPCS Level II code J1812 represents insulin (fiasp), per 5 units. This code is used to bill for doses of the fast-acting insulin formulation Fiasp administered in 5-unit increments.
Service Type: Medication administration / Pharmacy-dispensed drug
Typical Site of Service: Outpatient clinic, physician office, infusion center, or pharmacy
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with diabetes mellitus requiring rapid-acting insulin management who presents to an outpatient endocrinology clinic or pharmacy-managed diabetes education service for initiation or adjustment of fiasp (insulin aspart, ultra-rapid-acting). The encounter includes medication reconciliation, assessment of recent blood glucose logs or continuous glucose monitor (CGM) data, review of carbohydrate counting and insulin-to-carbohydrate ratios, counseling on injection technique and hypoglycemia management, and documentation of the exact number of 5-unit increments administered or furnished for billing with J1812. Typical sites of service include outpatient physician offices, outpatient clinics, retail pharmacies dispensing and teaching insulin administration, home health for patients unable to travel, and inpatient settings when documenting medication administration for billing or inventory reconciliation. The clinical workflow: medication review and indication documented; patient education and demonstration of injection or device use; prescription and dispensation of fiasp with record of units supplied; coding and billing staff attach J1812 per 5 units supplied or billed, along with any applicable modifiers representing the service circumstance; follow-up plan for glucose monitoring and dose titration is documented.
Coding Specifications
| Modifier | Description | When to Use |
|---|